SPH SINCLAIR PHARMA PLC ORD 1P
| Income Statement (£ m) | 30-Jun-11 | 30-Jun-12 | 30-Jun-13 | 30-Jun-14 | 30-Jun-15 |
|---|---|---|---|---|---|
| Continuing Operations | |||||
| Revenue | 32.90 | 51.42 | 55.38 | 63.56 | 75.89 |
| Operating Profit/(Loss) | -9.89 | -4.95 | -15.33 | -1.79 | 4.54 |
| Net Interest | 1.87 | 1.18 | 0.80 | 2.07 | 5.68 |
| Profit Before Tax | -11.74 | -6.23 | -16.98 | -4.44 | -8.15 |
| Profit After Tax | -11.67 | -5.10 | -15.85 | -4.09 | -7.21 |
| Discontinued Operations | |||||
| Profit After Tax | 0.00 | -3.54 | -1.52 | -1.21 | 0.00 |
| PROFIT FOR THE PERIOD | -11.67 | -8.64 | -17.36 | -5.30 | -7.21 |
| Attributable to: | |||||
| Minority Interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Holders of Parent Company | -11.67 | -8.64 | -17.36 | -5.30 | -7.21 |
| Continuing EPS | |||||
| Earnings per Share - Basic | -5.10p | -1.30p | -3.70p | -0.90p | -1.50p |
| Earnings per Share - Diluted | -5.10p | -1.30p | -3.70p | -0.90p | -1.50p |
| Earnings per Share - Adjusted | -1.30p | -1.30p | 0.70p | 1.30p | 2.00p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share - Basic | -5.10p | -2.20p | -4.10p | -1.20p | -1.50p |
| Earnings per Share - Diluted | -5.10p | -2.20p | -4.10p | -1.20p | -1.50p |
| Earnings per Share - Adjusted | -1.30p | -2.20p | 0.30p | 1.00p | 2.00p |
| Dividend per Share | 0.00p | 0.00p | 0.00p | 0.00p | 0.00p |
| Balance Sheet (£ m) | 30-Jun-11 | 30-Jun-12 | 30-Jun-13 | 30-Jun-14 | 30-Jun-15 |
|---|---|---|---|---|---|
| Assets | |||||
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.12 | 0.84 | 0.50 | 1.40 | 1.71 |
| Intangible Assets | 123.61 | 129.63 | 121.36 | 241.54 | 232.28 |
| Investment Properties | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.04 | 0.13 | 0.16 | 0.16 | 0.17 |
| Other Financial Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 4.42 | 4.81 | 4.16 | 3.85 | 3.31 |
| 132.18 | 135.40 | 126.17 | 246.95 | 237.47 | |
| Current Assets | |||||
| Inventories | 9.59 | 5.83 | 4.85 | 7.60 | 7.62 |
| Trade & Other Receivables | 15.27 | 16.78 | 19.94 | 29.54 | 27.66 |
| Cash at Bank & in Hand | 5.10 | 4.04 | 5.06 | 17.53 | 12.66 |
| Current Asset Investments | 3.41 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.43 | 0.00 | 1.10 | 0.00 |
| 33.37 | 27.08 | 29.85 | 55.77 | 47.95 | |
| Total Assets | 165.55 | 162.48 | 156.02 | 302.72 | 285.42 |
| Liabilities | |||||
| Current Liabilities | |||||
| Borrowings | -7.13 | -3.12 | -3.42 | -1.24 | -0.02 |
| Other Current Liabilities | -16.58 | -17.34 | -20.61 | -41.64 | -46.73 |
| -23.71 | -20.46 | -24.03 | -42.88 | -46.75 | |
| Net Current Assets | 9.66 | 6.62 | 5.82 | 12.89 | 1.20 |
| Non-Current Liabilities | |||||
| Borrowings | -9.70 | -9.98 | -8.50 | -53.32 | -51.78 |
| Provisions | -7.75 | -15.34 | -10.93 | -27.04 | -26.70 |
| Other Non-Current Liabilities | -0.48 | -2.41 | -2.02 | -61.57 | -54.62 |
| -17.93 | -27.74 | -21.45 | -141.93 | -133.10 | |
| Other Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Liabilities | -41.64 | -48.20 | -45.48 | -184.80 | -179.85 |
| Net Assets | 123.91 | 114.28 | 110.54 | 117.92 | 105.57 |
| Capital & Reserves | |||||
| Share Capital | 3.81 | 4.03 | 4.35 | 4.97 | 4.97 |
| Share Premium Account | 58.79 | 58.73 | 67.24 | 86.14 | 86.13 |
| Other Reserves | 102.96 | 100.67 | 104.83 | 96.97 | 90.41 |
| Retained Earnings | -41.65 | -49.15 | -65.88 | -70.16 | -75.94 |
| Shareholders Funds | 123.91 | 114.28 | 110.54 | 117.92 | 105.57 |
| Minority Interests/Other Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 123.91 | 114.28 | 110.54 | 117.92 | 105.57 |
| Ratios - based on IFRS | 30-Jun-11 | 30-Jun-12 | 30-Jun-13 | 30-Jun-14 | 30-Jun-15 |
|---|---|---|---|---|---|
| Continuing Operations | |||||
| PE Ratio - Adjusted | -21.83 | -20.58 | 37.86 | 24.62 | 20.00 |
| PEG - Adjusted | n/a | n/a | n/a | 0.29 | 0.37 |
| Earnings per Share Growth - Adjusted | n/a | n/a | n/a | 85.71% | 53.85% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Revenue Per Share | 14.30p | 13.13p | 12.98p | 14.29p | 15.27p |
| Pre-Tax Profit per Share | -5.10p | -1.59p | -3.98p | -1.00p | -1.64p |
| Operating Margin | -30.06% | -9.84% | -29.22% | -3.74% | -3.26% |
| Return on Capital Employed | -39.68% | -38.61% | -134.55% | 5.65% | 5.14% |
| Continuing & Discontinued Operations | |||||
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend per Share Growth | n/a | n/a | n/a | n/a | n/a |
| Net Asset Value per Share (exc. Intangibles) | 0.08p | -3.81p | -2.49p | -24.85p | -25.47p |
| Net Gearing | 9.47% | 7.93% | 6.20% | 31.40% | 37.07% |
Data is provided by Morningstar
Company Information
| Updated Monthly | |
|---|---|
| Company address | 1st Floor, Whitfield Court, 30-32 Whitfield Street, London, W1T 2RQ, United Kingdom |
| Company website | http://www.sinclairphar... |
| Market cap(in millions)* | £ 133.06 |
| Listing/Admission to trading | 06 Jun 2011 |
| Trading service | SETS |
| Market | AIM |
| Listing category | - |
Trading Information
| 29-Sep-16 | |
|---|---|
| FTSE index | FTSE AIM All-Share,FTSE AIM 100,FTSE AIM All-Share - Health Care |
| FTSE sector | Pharmaceuticals & Biotechnology |
| FTSE sub-sector | Pharmaceuticals |
| Country of share register | GB |
| Segment | AMSM |
| MiFID Status | MTF |
| Exchange market size | 10,000 |
| SEDOL | 3385674 |
| ISIN number | GB0033856740 |